Stock screenerAll disclosures → EDGAR →
CELZ
Conviction 4FinancialsScan · Mon, Aug 10, 2026CELZ$1.18-16.90%
ResistanceSupportVol 14Vol MA14 27.3M
May 11May 28Jun 16Jul 6Jul 23Aug 10
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.creativemedicaltechnology.com ↗
Price1.18
Change-16.90%
Gap-8.45%
Rel volume0.00×
Avg volume19.18M
Avg $ vol21.82M
SMA 200.8469
SMA 501.39
SMA 2002.08
Price vs 50-15.35%
Price vs 200-43.15%
MA stackbearish
50/200 cross—
Supertrendup · 0.8093
RSI (14)55
MACD hist0.10
MACD cross—
Stoch %K / %D42 / 50
ADX (14)29
+DI / −DI46 / 16
RSI divergence—
MACD divergenceBullish
ATR %+21.42%
ADR %13.63%
52w high5.59
52w low0.6542
From 52w high-78.89%
Above 52w low+80.37%
New 52w highNo
SqueezeOff
Bollinger width89.66%
%B0.94
Donchian pos42.42%
Donchian high1.94
Donchian low0.6200
AVWAP (52w high)1.69
vs AVWAP high-30.07%
AVWAP (52w low)1.27
vs AVWAP low-7.20%
OBV trendUp
Chaikin MF (20)-0.54
Today vs 20d0.00×
Avg vol (14d)27.3M
Avg vol (20d)19.18M
Avg $ vol (20d)21.82M
Market cap—
RS 3m (vs SPY)-43.69%
RS 6m (vs SPY)-34.34%
RS line new highNo
Trend template1/8
Technical rank27.7
1 week+80.37%
1 month+29.37%
3 months-48.92%
6 months-38.86%
1 year-68.36%
YTD-40.10%
P/E-1.57
P/B1.09
P/S—
P/FCF—
EPS-2.52
Div yield—
ROE-69.27%
ROA-63.93%
Debt/Eq0.59
Current12.91
EV/EBITDA-1.65
Gross margin63.43%
Net margin—
Rev growth-45.45%
EPS growth-9.13%
Price target20.00
Target upside1298.60%
Analyst ratingBuy
Institutional2.68%
Ent. value10.07M
Revenue0
Net income-1.51M
Gross profit0
Free cash flow—
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out3.7M
Employees4
ListedThu, Apr 30, 2009
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank27.7 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.61
Support0.7050
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CELZ
No recent disclosed trades by Congress in CELZ. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CELZ
No recent insider (Form 4) filings in CELZ. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in CELZ · 8 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.